Cholangiocarcinoma (CC) is a devastating cancer arising from biliary epithelia. Unfortunately, the incidence of this disease is increasing in Western countries. These tumors progress insidiously, and liver failure, biliary sepsis, malnutrition and cancer cachexia are general modes of death associated with this disease. To date, no established therapy for advanced disease has been established or validated. However, our knowledge in tumor biology is increasing dramatically and new drugs are under investigation for treatment of this notorious tumor. In clinical practice, there are better diagnostic tools in use to facilitate an earlier diagnosis of CC, at least in those patients with known risk factors. CC is resectable for cure in only a smal...
Cholangiocarcinoma (CC) represent 3% of all gastrointestinal tumours and can be classified anatomica...
Despite being the second most frequent primary liver tumor in humans, early diagnosis and treatment ...
Cholangiocarcinoma (CC) represent 3% of all gastrointestinal tumours and can be classified anatomica...
Cholangiocarcinoma (CC) is a devastating cancer arising from biliary epithelia. Unfortunately, the i...
SummaryCholangiocarcinoma represents a diverse group of epithelial cancers united by late diagnosis ...
Cholangiocarcinoma was first reported by Durand-Fardel in 1840.1 The tumour arises from the ductular...
Cholangiocarcinoma (CC) represent 3% of all gastrointestinal tumours and can be classified anatomica...
Cholangiocarcinoma is commonly described as any malignancy arising from the lining of the bile duct ...
Cholangiocarcinoma (CCA) is a neoplasm with high mortality that represents 15% of all primary liver ...
Cholangiocarcinoma is the second most common primary hepatic tumour after hepatocellular carcinoma. ...
: Despite being the second most frequent primary liver tumor in humans, early diagnosis and treatmen...
: Despite being the second most frequent primary liver tumor in humans, early diagnosis and treatmen...
: Despite being the second most frequent primary liver tumor in humans, early diagnosis and treatmen...
: Despite being the second most frequent primary liver tumor in humans, early diagnosis and treatmen...
Cholangiocarcinoma (CCA) is a group of malignant tumours that originates from the biliary tree. Depe...
Cholangiocarcinoma (CC) represent 3% of all gastrointestinal tumours and can be classified anatomica...
Despite being the second most frequent primary liver tumor in humans, early diagnosis and treatment ...
Cholangiocarcinoma (CC) represent 3% of all gastrointestinal tumours and can be classified anatomica...
Cholangiocarcinoma (CC) is a devastating cancer arising from biliary epithelia. Unfortunately, the i...
SummaryCholangiocarcinoma represents a diverse group of epithelial cancers united by late diagnosis ...
Cholangiocarcinoma was first reported by Durand-Fardel in 1840.1 The tumour arises from the ductular...
Cholangiocarcinoma (CC) represent 3% of all gastrointestinal tumours and can be classified anatomica...
Cholangiocarcinoma is commonly described as any malignancy arising from the lining of the bile duct ...
Cholangiocarcinoma (CCA) is a neoplasm with high mortality that represents 15% of all primary liver ...
Cholangiocarcinoma is the second most common primary hepatic tumour after hepatocellular carcinoma. ...
: Despite being the second most frequent primary liver tumor in humans, early diagnosis and treatmen...
: Despite being the second most frequent primary liver tumor in humans, early diagnosis and treatmen...
: Despite being the second most frequent primary liver tumor in humans, early diagnosis and treatmen...
: Despite being the second most frequent primary liver tumor in humans, early diagnosis and treatmen...
Cholangiocarcinoma (CCA) is a group of malignant tumours that originates from the biliary tree. Depe...
Cholangiocarcinoma (CC) represent 3% of all gastrointestinal tumours and can be classified anatomica...
Despite being the second most frequent primary liver tumor in humans, early diagnosis and treatment ...
Cholangiocarcinoma (CC) represent 3% of all gastrointestinal tumours and can be classified anatomica...